Williams Sarah Joanne
Principal Accounting Officer
Williams Sarah Joanne has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Williams Sarah Joanne is listed as Principal Accounting Officer at AN2 Therapeutics, Inc. Inside the rolling window, Williams Sarah Joanne reported no open-market purchases and 3 open-market sales totaling $3K in ANTX. The largest disclosed transaction in the window is a sale of 272 ANTX shares on Sep 1, 2026, worth $2K.
Companies traded
Other insiders at ANTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Williams Sarah Joanne made?
Williams Sarah Joanne has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Williams Sarah Joanne trade?
Williams Sarah Joanne has filed SEC Form 4 disclosures for 1 company, including ANTX.
When was Williams Sarah Joanne's most recent SEC Form 4 filing?
Williams Sarah Joanne's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Williams Sarah Joanne's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Williams Sarah Joanne is listed as Principal Accounting Officer.
What is Williams Sarah Joanne's total buy and sell value in the current window?
Inside the rolling retention window, Williams Sarah Joanne bought $0 and sold $3K based on SEC Form 4 filings.
What was Williams Sarah Joanne's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 272 ANTX shares on 2026-09-01, worth $2K, per SEC Form 4 filings.